Need Help? Call 1­-866-­796-­7386
« back to stock screener

  HALO stock: Halozyme Therapeutics, Inc.

Current Rating
Sell

Previous Rating

Strong Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$25.93
Market Cap
3.81B
Sector
Health Care
Div. Growth
-
P/E
-
P/B
36.62
P/S
21.42
Dividend %
-
P/CF
59.8
P/FCF
-
Op. Cash Flow
-57.8K
FCF
-0.4
Op. Margin
-16.80%
Net Margin
-22.00%
ROE
-31.70%
ROI
-13.70%
ROA
-8.10%
EPS Growth
9.00%
Current Ratio
6.3
Debt/Equity
417.20%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Diversicare Healthcare Service (DVCR) $1.65 - - 13.3M Strong Buy
Titan Pharmaceuticals, Inc. (TTNP) $0.21 - - 23M Strong Buy
Tivity Health Inc (TVTY) $14.03 - - 783.8M Strong Buy
Amneal Pharmaceuticals Inc (AMRX) $3.85 - - 1.23B Strong Buy
Navidea Biopharmaceuticals Inc (NAVB) $2.91 - - 70.1M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More